Breaking News Instant updates and real-time market news.

NFLX

Netflix

$346.40

13.29 (3.99%)

09:26
10/17/18
10/17
09:26
10/17/18
09:26

Netflix price target raised to $150 from $125 at Wedbush

Wedbush analyst Michael Pachter raised his price target for Netflix to $150 from $125 following quarterly results. The analyst expects content acquisition spending to trigger substantial cash burn for many years. Notwithstanding three Netflix price increases in the last five years, cash burn continues to grow, he notes. Further, the analyst says international profits may remain elusive due to competition for content and subscriptions, and last year's price increases could cause a deceleration in subscriber growth. He reiterates an Underperform rating on the shares.

  • 13

    Nov

NFLX Netflix
$346.40

13.29 (3.99%)

10/17/18
RBCM
10/17/18
NO CHANGE
Target $450
RBCM
Outperform
Netflix price target raised to $450 from $440 at RBC Capital
RBC Capital analyst Mark Mahaney raised his price target on Netflix to $450 and kept his Outperform rating after its Q3 earnings beat. The analyst notes that the company delivered a "beat and raise" quarter of net subscriber additions following a weak Q2, with observed contribution coming from domestic and international segments. Mahaney maintains that Netflix's streaming revenue and subscriber addition trends of acceleration for FY18, along with the company's positive long-term fundamentals, remain "very much intact".
10/17/18
BERN
10/17/18
NO CHANGE
BERN
Pace of Netflix subscriber growth 'astounding,' says Bernstein
Bernstein analyst Todd Juenger says that while Netflix's rare subscriber miss last quarter caused investors to question whether it as just a blip or an early warning of deceleration, this quarter's blow out result seems to put that debate to rest. The pace of Netflix subscriber growth is "astounding," he contends. The analyst notes that it took 10 years to go from 0 to 100M paid subscriptions, but he projects it will take only 2 years to go from 100M to 150M.
10/17/18
IMPC
10/17/18
NO CHANGE
Target $464
IMPC
Outperform
Netflix price target lowered to $464 from $494 at Imperial Capital
Imperial Capital analyst David Miller lowered his price target for Netflix to $464 while keeping an Outperform rating on the shares following last night's Q3 results. The Q4 guidance is "slightly light on most metrics," Miller tells investors in a post-earnings research note. He notes his new price target still implies 34% upside.
10/17/18
LOOP
10/17/18
NO CHANGE
Target $385
LOOP
Hold
Netflix price target raised to $385 from $365 at Loop Capital
Loop Capital analyst Alan Gould raised his price target on Netflix (NFLX) to $385 from $365 after its reported strong subscription adds in Q3 and expectations of more adds in Q4. The analyst also points to the management's FY19 operating margin target of 13% - up from 10%-11% target for FY18 - and expectations of "peak" negative free cash flows in the next two years. Gould also keeps his Hold rating on Netflix given the ongoing risks around competition from Amazon (AMZN) and other content providers along with a strong USD weighing on international sales.

TODAY'S FREE FLY STORIES

YRD

Yirendai

$15.47

-1.75 (-10.16%)

17:01
11/12/18
11/12
17:01
11/12/18
17:01
Earnings
Yirendai reports Q3 adjusted income per ADS 87c, consensus 52c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LTM

Latam Airlines

$8.96

-0.39 (-4.17%)

17:00
11/12/18
11/12
17:00
11/12/18
17:00
Hot Stocks
Latam Airlines reports October passenger traffic up 1.5% »

LATAM Airlines Group …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ETON

Eton Pharmaceuticals

$0.00

(0.00%)

16:53
11/12/18
11/12
16:53
11/12/18
16:53
Syndicate
Eton Pharmaceuticals 3.6M share IPO priced at $6.00 »

National Securities acted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$60.18

-1.235 (-2.01%)

16:49
11/12/18
11/12
16:49
11/12/18
16:49
Hot Stocks
Energizer names Patrick Moore chairman of the board »

Energizer Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ACIU

AC Immune

$8.74

0.01 (0.11%)

16:47
11/12/18
11/12
16:47
11/12/18
16:47
Initiation
AC Immune initiated  »

AC Immune initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNT

Kornit Digital

$19.15

-0.88 (-4.39%)

16:47
11/12/18
11/12
16:47
11/12/18
16:47
Earnings
Kornit Digital reports Q3 adjusted EPS 13c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ZGNX

Zogenix

$40.82

0.05 (0.12%)

16:46
11/12/18
11/12
16:46
11/12/18
16:46
Initiation
Zogenix initiated  »

Zogenix initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ADMS

Adamas Pharmaceuticals

$11.45

-0.455 (-3.82%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Adamas Pharmaceuticals initiated  »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 27

    Nov

  • 27

    Nov

AGN

Allergan

$163.82

-1.77 (-1.07%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Allergan initiated  »

Allergan initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SAGE

Sage Therapeutics

$121.50

-9.46 (-7.22%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Sage Therapeutics initiated  »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

  • 19

    Dec

NBIX

Neurocrine

$103.03

-2.18 (-2.07%)

16:44
11/12/18
11/12
16:44
11/12/18
16:44
Initiation
Neurocrine initiated  »

Neurocrine initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HLUYY

Lundbeck

$0.00

(0.00%)

16:44
11/12/18
11/12
16:44
11/12/18
16:44
Initiation
Lundbeck initiated  »

Lundbeck initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$134.48

-3.3 (-2.40%)

16:43
11/12/18
11/12
16:43
11/12/18
16:43
Initiation
GW Pharmaceuticals initiated  »

GW Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

BHVN

Biohaven Pharmaceutical

$36.42

-2.47 (-6.35%)

16:42
11/12/18
11/12
16:42
11/12/18
16:42
Initiation
Biohaven Pharmaceutical initiated  »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 27

    Nov

ACAD

Acadia

$18.86

-0.01 (-0.05%)

16:42
11/12/18
11/12
16:42
11/12/18
16:42
Initiation
Acadia initiated  »

Acadia initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ALKS

Alkermes

$34.70

-2.98 (-7.91%)

16:41
11/12/18
11/12
16:41
11/12/18
16:41
Initiation
Alkermes initiated  »

Alkermes initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 31

    Jan

GATX

GATX

$76.43

-2.54 (-3.22%)

16:37
11/12/18
11/12
16:37
11/12/18
16:37
Hot Stocks
GATX acquires up to 3,100 railcars for $229M »

GATX Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVGS

Navigator Holdings

$12.03

-0.13 (-1.07%)

16:35
11/12/18
11/12
16:35
11/12/18
16:35
Earnings
Navigator Holdings reports Q3 EPS 1c, consensus (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GRA

W.R. Grace

$63.83

-0.705 (-1.09%)

16:35
11/12/18
11/12
16:35
11/12/18
16:35
Hot Stocks
W.R. Grace to increase price for silica-based, molecular sieve products by 7% »

W. R. Grace will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:34
11/12/18
11/12
16:34
11/12/18
16:34
Hot Stocks
AXA Equitable reports Q3 annualized premiums up 2% »

Reports Q3 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:33
11/12/18
11/12
16:33
11/12/18
16:33
Hot Stocks
Breaking Hot Stocks news story on AXA Equitable »

AXA Equitable announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:32
11/12/18
11/12
16:32
11/12/18
16:32
Earnings
AXA Equitable reports Q3 adjusted EPS $1.23, consensus 91c »

Reports Q3 revenue $1.08B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

HAL

Halliburton

$34.17

-0.81 (-2.32%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Halliburton names Lance Loeffler as CFO, Chris Weber to leave company »

Halliburton is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELVT

Elevate Credit

$4.11

-0.08 (-1.91%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Elevate Credit appoints David Peterson Chief Credit Officer »

Elevate Credit announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROP

Roper Technologies

$289.16

-7.67 (-2.58%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Roper Technologies raises quarterly dividend 12% to 46.25c per share »

Roper Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.